Rockefeller Capital Management’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Other funds holding RCUS
SL
Rockefeller Capital Management's RCUS Position: Q3 2026 in Review
Rockefeller Capital Management reduced its Arcus Biosciences (RCUS) stake by 3.3% in Q3 2026, selling an estimated $11.8K and leaving 12,315 shares worth $318K. The position accounts for ﹤0.01% of the portfolio, ranked #2392.
Rockefeller Capital Management first reported a position in RCUS in Q2 2022 and has held it in 8 quarters since. The position peaked at $393K in Q2 2026. 177 funds tracked by Wall St. Rank hold RCUS as of Q3 2026.
- Rockefeller Capital Management held 12,315 shares of Arcus Biosciences worth $318K as of Q3 2026.
- Rockefeller Capital Management sold 417 Arcus Biosciences shares in Q3 2026, an estimated $11.8K.
- Arcus Biosciences made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #2392 holding.
- Rockefeller Capital Management first reported a position in Arcus Biosciences in Q2 2022 and has held it in 8 quarters since.
- Rockefeller Capital Management's Arcus Biosciences position peaked at $393K in Q2 2026.
- 177 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2026.
Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.